The task at hand is not an easy one.  As well as the challenge in developing an infrastructure for the new medicinal cannabis industry, law makers need to consider the needs of those suffering from debilitating medical conditions and the current risk of prosecution each person faces each time they seek relief from their chronic medical conditions.  Adoption of medicinal cannabis legislation is the right action and now is the right time.

The presentation sets forth a workable, well organised programme for both legislation and development of the industry.  The initiatives proposed will generate significant outside investment providing the capital needed to develop a nationwide infrastructure.  Given the labour intensive nature of the industry and that patients will come from across the UK and from all walks of life, jobs created will be  spread right across the country. More than 100,000 new jobs will improve the economies of countless communities and spark entrepreneurial enthusiasm which will, in turn, create additional new jobs.

The ripple effect of these new jobs will have an enormously positive effect on the economy of the whole of the UK in a relatively short time. The job multiplier effect  could create as many as two to two-and-a-half times more indirect support jobs needed to manufacture and/or procure the materials and sophisticated equipment necessary to operate this new industry and to monitor its governance.  Sophisticated products and well educated and industry trained personnel (both blue and white collar) are required.

What has been proposed in the presentation will require hard work, long hours of dedicated effort and the collaborative cooperation of all; everyone pulling together to bring about a new 21st century perspective that relegates the thinking of the past to the history books and gives birth to a whole new industry with an abundance of new economic opportunities.

The Medicine Wheel Project LLC

The Alekson Group

Download the full 158 page presentation here

100,000 Well Paid UK Jobs Through Compassionate Medicinal Cannabis Legislation - CLEAR UK: Cannabis Law Reform Party

By Jim Alekson

TETRACAN MEDICAL MARIJUANA PATCH

HEALTHSTYLE v/s LIFESTYLE

The TETRACAN Medical Marijuana Patch is currently being developed in the United States by Medical Marijuana Delivery Systems LLC.  Once perfected, and when medical marijuana legislation is finally adopted in the United Kingdom, TETRACAN will be introduced to the UK under the brand name CANNIDERM.  The TETRACAN Medical Marijuana Patch is a dosage controlled, holistic medicinal therapy; not to be confused with a marijuana lifestyle.

The patented technology behind the TETRACAN Medical Marijuana Patch is the first exclusively controlled modality that establishes a clear differentiation and medicinal departure from marijuana’s age old delivery modality of smoking.  Introduction of TETRACAN products eliminates marijuana’s long-standing debate of “LifeStyle” v/s “HealthStyle”.  Use of TETRACAN holistic products, by registered medical marijuana patients, is clearly a HealthStyle choice. Those that advocate in  favor of marijuana as a holistic HealthStyle are clearly separated from those who argue to the contrary.

Although cannabis is typically smoked or eaten to reap its medical benefits, it is now possible to focus pain relief to the areas where it is needed by using topical products absorbed through the skin.  What is not generally known about medical marijuana is that getting “high” through smoking or eating marijuana is one of the potentially unwanted side-effects of medical marijuana therapy. TETRACAN transdermally delivered products are able to provide the same level of pain relief with none of the side-effects of marijuana use.

There are a significant number of persons in the base population, especially the young and the elderly, for whom the pain management benefits of medical marijuana therapy would be a welcome addition to their pain management options.  Unfortunately for any number of reasons including, but not limited to the following, they cannot include medical marijuana amongst their pain management options:

(i) those persons who cannot draw smoke into their lungs or eat medical marijuana products because of their medical condition;

(ii) those persons who are either too young or too elderly for normal medical marijuana therapy delivery modalities (smoking in particular).  This is especially applicable to persons suffering from the side-effects of chemotherapy;

(iii) the elderly who have never smoked in their lives and do not want to start even though the smoke is therapeutically beneficial to their quality of life; and

(iv) general societal misgivings about marijuana because of the perceived social stigma attributed to marijuana use.

These persons, as well as other medical marijuana patients who currently either smoke or eat medical marijuana products, will soon have a viable and societally acceptable alternative available to them in the form of the TETRACAN Medical Marijuana Patch.

TETRACAN products are also being perfected for veterinary applications to help alleviate the pain suffered by older pets.  The TETRACAN Pet Patch will soon be available on veterinary shelves across the United States.

Furthermore, introduction of dosage controlled TETRACAN patented products will:

(i) help block black market product proliferation and non-taxable profiteering;

(ii) for the first time, medical marijuana therapy can be dispensed in controlled dosages; and

(iii) open the door for the company’s research and development of other purely holistic delivery modalities involving both marijuana as well as other holistic medicinal compounds.

Could This Be An “Acceptable” Form Of Medicinal Cannabis? - CLEAR UK: Cannabis Law Reform Party